With box warnings

Without box warnings

Branded

Generic

4 results

actemra
(tocilizumab)
Genentech, Inc.
Usage: ACTEMRA (tocilizumab) is indicated for treating moderately to severely active rheumatoid arthritis, giant cell arteritis, systemic sclerosis-associated interstitial lung disease, polyarticular and systemic juvenile idiopathic arthritis, severe cytokine release syndrome, and COVID-19 in hospitalized adults receiving systemic corticosteroids.
avtozma
(tocilizumab)
CELLTRION USA, Inc.
Usage: AVTOZMA® (tocilizumab-anoh) is indicated for adults with moderately to severely active rheumatoid arthritis, giant cell arteritis, and hospitalized adults with COVID-19. It also treats active polyarticular and systemic juvenile idiopathic arthritis in patients aged 2 years and older.
olumiant
(baricitinib)
Eli Lilly and Company
Usage: OLUMIANT (baricitinib) is indicated for the treatment of adults with moderately to severely active rheumatoid arthritis, COVID-19 requiring oxygen support, and severe alopecia areata. However, it is not recommended for use with other JAK inhibitors, biologic DMARDs, or potent immunosuppressants.
tocilizumab-anoh
(tocilizumab)
CELLTRION USA, Inc.
Usage: Tocilizumab-anoh is indicated for treating moderately to severely active rheumatoid arthritis, giant cell arteritis, polyarticular and systemic juvenile idiopathic arthritis (ages 2+), and COVID-19 in hospitalized adults requiring respiratory support while on systemic corticosteroids.

Medications for Covid19 Virus Disease

actemra